Cabozantinib

From Ganfyd

Jump to: navigation, search

Contents

Introduction

A tyrosine kinase inhibitor with activity against several receptors, in particular:

Clinical Use

It is being developed to treat medullary carcinoma of the thyroid and bone metastatic disease.

Indications

Administration

Oral

Clinical Issues

Contra-indications

Cautions and Interactions

Side effects

Special advice

Pharmacology